Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Oncology Reports is Scopus-indexed (Q1, CiteScore 7.7), WoS SCIE. Published by Spandidos Publications.
Checked against the index lists dated .
ISSN 1021-335XVerify ISSN ↗1791-2431Verify ISSN ↗
Publisher: Spandidos Publications
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 76 / 428 | 82nd | Q1 |
| Cancer Research | 66 / 233 | 71st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1994–present, best quartile Q1, CiteScore 7.7.
Oncology Reports is Q1 in Oncology (rank 76 of 428) and Q2 in Cancer Research (rank 66 of 233), by CiteScore 2025.
Oncology Reports is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.7, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.887, quartile Q2, with an H-index of 125.
Oncology Reports is published by Spandidos Publications. Its print ISSN is 1021-335X and its online ISSN is 1791-2431.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Oncology Reports has an h-index of 133 and a 2-year mean of 2.99 citations per paper (OpenAlex). Its Scopus CiteScore is 7.7, quartile Q1. On 2-year citations it ranks #113 of 424 Scopus journals in Oncology.
Oncology Reports published 179 papers in 2025; its busiest recent year was 2017 with 832. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (76.5%), Japan (7.7%) and South Korea (5.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 395 retracted papers are recorded (29 per 1,000 papers). The Problematic Paper Screener flags 442 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.